Controlling and Preventing STIs in US Health Departments (CAP-STIs)
Status: Open
Posted date: May 11, 2026
Archive date: September 28, 2026
Opportunity ID: 362349
Opportunity number: CDC-RFA-PS-27-0008
Opportunity category: Discretionary
Agency name: Centers for Disease Control - NCHHSTP
Agency code: HHS-CDC-NCHHSTP
Award floor: $0
Award ceiling: $0
Cost sharing required: No
Funding Instrument Types
- Cooperative Agreement
Category of Funding Activity
- Health
Eligible Applicants
- City or township governments
- County governments
- Others
- Special district governments
- State governments
- Unrestricted
Categories (use these for quoted searches)
- agency_code:hhs_cdc_nchhstp
- category_of_funding_activity:health
- cost_sharing_or_matching_requirement:false
- eligible_applicants:city_or_township_governments
- eligible_applicants:county_governments
- eligible_applicants:others
- eligible_applicants:special_district_governments
- eligible_applicants:state_governments
- eligible_applicants:unrestricted
- funding_instrument_type:cooperative_agreement
- opportunity_category:discretionary
- status:open
CDC is funding programs that track, prevent, and control sexually transmitted infections (STI) in state, district, territorial, and city or county health departments.The purpose of this NOFO is to track, prevent, and control three common STIs: syphilis, gonorrhea, and chlamydia.The NOFO supports the goals of the Sexually Transmitted Infections National Strategic Plan 2021-2025:Prevent new STIs.Improve the health of people by reducing adverse outcomes of STIs.Implement STI prevention technology and innovations more quickly.Reduce the impact of STIs in areas or populations disproportionately impacted by STIs.Achieve integrated, coordinated efforts that address the STI epidemic.Local surveillance data will determine the priority populations for this NOFO. Each program should focus on populations that are disproportionately impacted by STI transmission. To be successful with this NOFO, you will need to collaborate with partners to address interconnected comorbidities and sexual health.